Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Overactive Bladder
UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Search    Display results per page
Results 61 - 75 of 663
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release - Abstract
Wednesday, 26 August 2009
Department of Urology, William Beaumont Hospital, Detroit, Michigan.
read more

Patient Guide - Controlling Your Bladder Symptoms
Tuesday, 25 August 2009
Login to read more...

A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder - Abstract
Tuesday, 25 August 2009
Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, USA.
read more

URS 2009 - Effects of a novel peripheral selective cannabinoid-2-receptor agonist (Cannabinor) on bladder function in normal rats and rats with partial urethral obstruction - Abstract
Monday, 24 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - The aim of the current study was to characterize the distribution of the cannabinoid-2-receptor (CB2) in the rat bladder and to study effects of Cannabinor, a peripherally acting selective CB2 agonist, on isolated rat detrusor and on bladder function during cystometry in normal rats and rats with partial urethral obstruction.
Login to read more...

URS 2009 - Urothelium-derived inhibitory factors and the human neurogenic overactive bladder - Abstract
Monday, 24 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - The urothelium (urothelium plus suburothelium) has been shown to release a diffusible factor that inhibits the underlying detrusor smooth muscle.
Login to read more...

URS 2009 - ATP release in response to acid and capsaicin provides evidence for sensory roles of vanilloid and ASIC receptor systems in the rat bladder mucosa - Abstract
Monday, 24 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - ATP has important sensory and motor functions in the urinary bladder.
Login to read more...

URS 2009 - TRPV4 as a mechanoreceptor in the human bladder: A co-localization between TRPV4 and adherence junctions in the human bladder urothelium - Abstract
Monday, 24 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - Transient receptor potential vanilloid receptor 4 (TRPV4) is a calcium specific ion-channel that is activated by physical stimuli like ‘stretch.’
Login to read more...

Tolterodine extended release is well tolerated in older subjects - Abstract
Monday, 24 August 2009
Department of Urology and The Landon Center on Aging, University of Kansas, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
read more

Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: Results from the overactive bladder innovative therapy trial - Abstract
Friday, 21 August 2009
William Beaumont Hospital, Royal Oak, Michigan, USA.
read more

Bladder sensation measures and overactive bladder - Abstract
Thursday, 20 August 2009
Continence Center at Virginia Mason Medical Center, Seattle, Washington 98111, USA.
read more

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence - Abstract
Wednesday, 19 August 2009
University of New Mexico School of Medicine, Albuquerque, NM, USA.
read more

Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: a review - Abstract
Tuesday, 18 August 2009
Urogynecology and Vaginal Surgery Section, Department of Gynecology, Federal University of São Paulo, São Paulo, Brazil.
read more

Basic mechanisms of urgency: roles and benefits of pharmacotherapy - Abstract
Monday, 17 August 2009
Department of Pharmacology and Pharmacotherapy, Academic Medical Center, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
read more

Ultrasonographic bladder measurements can replace urodynamic study for the diagnosis of non-monosymptomatic nocturnal enuresis - Abstract
Friday, 14 August 2009
Departments of Paediatrics and Radiology, Second University of Naples, Naples, Italy.
read more

Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery - Abstract
Wednesday, 12 August 2009
Department of Urology, William Beaumont Hospital, 3535 W. 13 Mile Road, Suite 430 MOB, Royal Oak, MI, 48073, USA.
read more

World Continence Week 2009

Patient Guide - Controlling Your Bladder Symptoms

- Prepared by Diane K. Newman, MSN, CRNP, FAAN, BCIA-PMDM

Promoting Continence Worldwide

- Prepared by Diane K. Newman, MSN, CRNP, FAAN, BCIA-PMDM

Urinary Incontinence: Epidemiology and Disease Burden

- Prepared by Alan J. Wein, MD, PhD (hon)




Meet the Expert

Meet the Expert - Diane K. Newman



CME Activity

Overactive Bladder Management: Thinking Beyond Urgency and Frequency

 

Focus on Overactive Bladder

Focus on Overactive Bladder condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.





- International Consultation on Incontinence - ICI 2008

- Session Abstracts, Overactive Bladder



A Review of Adherence to Drug Therapy in Patients with Overactive Bladder

- BJUI Mini Reviews



Emerging Drugs for Treatment of Overactive Bladder and Detrusor Overactivity

- Beyond the Abstract

A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder

- Beyond the Abstract

Darifenacin Treatment for Overactive Bladder in Patients Who Expressed Dissatisfaction With Prior Extended-Release Antimuscarinic Therapy

- Beyond the Abstract

Podcast - Effective Darifenacin Treatment after Dissatisfaction with Prior Extended-Release Antimuscarinic Therapy

- Listen to an interview with the lead investigator of this study, Dr. Norman Zinner



Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

- BJUI Mini Reviews



Defining Overactive Bladder as Hypersensitivity

- Editorial by Philip M. Hanno, MD

Lower Urinary Tract Symptomatology: Its Definition and Confusion

- Editorial by Philip M. Hanno, MD



A Review of Adherence to Drug Therapy in Patients with Overactive Bladder

- BJUI Mini Reviews




Overactive Bladder in Conferences



Image

Session Highlights from the Society for Urodynamics & Female Urology 2009 Winter Meeting


- Exclusive Coverage by UroToday.com Contributing Medical Writer, William Jaffe, MD

Image

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at The National Institutes of Health (NIH) - UI Symposium

- Session Highlights Reported by Diane K. Newman

Image

Overactive Bladder: Management and Treatment Options

- Presented by E. Ann Gormley, MD, FACS, at the Masters in Urology Meeting


Drug Treatment - Lecture Series


- Presented by Karl-Erik Andersson, MD, PhD, and Christopher Chapple, MD, et al. at the Fourth International Consultation on Incontinence (ICI)

Drug Treatment - Committee Meeting Highlights

- Reported by William Jaffe, MD from the Fourth International Consultation on Incontinence (ICI)

Image

Voiding Dysfunction Session Highlights


- From the American Urological Association 2008 Annual Meeting


Urodynamics and Reality


- Presented by Ed McGuire, MD, at the 32nd Winter Urologic Forum


Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder

- Presented at the European Association of Urology - 23rd Annual EAU Congress

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 61 - 75 of 663

Member's Section

Login

Sign Up

Quick Search

Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Overactive Bladder
Sponsored By